Yanglong Guo

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 3

Top Topics

Radiation Therapy

Palliative Care

Mesenchymal Stem Cells

Top Venues

Current cancer drug targets

This page only lists publications with an associated author ORCID identifier.

Publications

Yanglong Guo, Xi Chen, Xuedong Tang, Shan Pan, Tao Zhu, Yingli Zhang
Real-world Study on the Effect of PARPi as Maintenance Therapy on Platinum Sensitivity after First- and Second-line Chemotherapy in Patients with Recurrent High-grade Serous Epithelial Ovarian Cancer. Current cancer drug targets 24 (7) (2024)
Yanglong Guo, Xi Chen, Xuedong Tang, Shan Pan, Tao Zhu, Yingli Zhang
Real-world Study on the Effect of PARPi as Maintenance Therapy on Platinum Sensitivity after First- and Second-line Chemotherapy in Patients with Recurrent High-grade Serous Epithelial Ovarian Cancer. Current cancer drug targets (2024)
Yanglong Guo, Xi Chen, Xuedong Tang, Shan Pan, Tao Zhu, Yingli Zhang
Real-world Study on the Effect of PARPi as Maintenance Therapy on Platinum Sensitivity after First- and Second-line Chemotherapy in Patients with Recurrent High-grade Serous Epithelial Ovarian Cancer. Current cancer drug targets 24 (7) (2024)